Inventor · disambiguated record
Scott Young
Also filed as: YOUNG SCOTT · YOUNG SCOTT A · YOUNG SCOTT W
16 granted patents·10 pending applications·205 citations·filing 2003–2024
95Inventor score
Files withALDEYRA THERAPEUTICS INC22CHAPLIN DAVID J1DOW GLOBAL TECHNOLOGIES INC1MALOUF ALFRED1OXIGENE INC1
Top patents by PatentIndex Score
26 records- 0198US11007157B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2020·Granted May 18, 2021·15 cites·41 claims
- 0297US11771664B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2022·Granted Oct 3, 2023·4 cites·16 claims
- 0397US11701331B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2021·Granted Jul 18, 2023·7 cites·41 claims
- 0497US11459300B2Deuterated compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Oct 4, 2022·10 cites·20 claims
- 0597US11046650B2Deuterated compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·16 cites·19 claims
- 0697US10550085B2Deuterated compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2016·Granted Feb 4, 2020·20 cites·20 claims
- 0796US11845722B2Deuterated compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2022·Granted Dec 19, 2023·7 cites·22 claims
- 0896US10588874B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2019·Granted Mar 17, 2020·20 cites·41 claims
- 0996US10543181B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2019·Granted Jan 28, 2020·17 cites·30 claims
- 1096US10213395B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2017·Granted Feb 26, 2019·24 cites·40 claims
- 1195US11129823B2Combination treatment of ocular inflammatory disorders and diseasesALDEYRA THERAPEUTICS INC·Filed 2017·Granted Sep 28, 2021·12 cites·4 claims
- 1295US9687481B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2014·Granted Jun 27, 2017·28 cites·35 claims
- 1395US2025127733A1Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1494US10426790B2Treatment of allergic eye conditions with cyclodextrinsALDEYRA THERAPEUTICS INC·Filed 2017·Granted Oct 1, 2019·20 cites·30 claims
- 1592US12128013B2Toxic aldehyde related diseases and treatmentALDEYRA THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·0 cites·20 claims
- 1684US12240816B2Deuterated compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·0 cites·20 claims
- 1774US7358236B1Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agentsOXIGENE INC·Filed 2003·Granted Apr 15, 2008·5 cites·13 claims
- 1868US2022354857A1Aldehyde conjugates and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1966US2020246345A1Aldehyde conjugates and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2064US2022184057A1Combination treatment of ocular inflammatory disorders and diseasesALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2159US2010168010A1Compositions and methods of modulating cell growth and motilityMALOUF ALFRED·Filed 2007·Application pending·0 cites
- 2251US2020062712A1Aldehyde trapping compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2351US2018250306A1Aldehyde conjugates and uses thereofALDEYRA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2450US2005209310A1Methods for modulating tumor growth and metastasisCHAPLIN DAVID J·Filed 2004·Application pending·0 cites
- 2547US2018050989A1Aldehyde trapping compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2640US2006210479A1Targeting chelants and chelatesDOW GLOBAL TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →